Narrowing in on Cardiovascular Disease: The Atheroprotective Role of Peroxisome Proliferator–Activated Receptor γ
Peroxisome proliferator–activated receptor γ (PPAR γ ) is a nuclear receptor that has been suggested to play protective roles in the pathogenesis of diseases that are characterized by chronic inflammation, such as atherosclerosis. The study of nuclear receptors, including PPAR γ , has led to the dis...
Gespeichert in:
Veröffentlicht in: | Trends in cardiovascular medicine 2008-02, Vol.18 (2), p.39-44 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 44 |
---|---|
container_issue | 2 |
container_start_page | 39 |
container_title | Trends in cardiovascular medicine |
container_volume | 18 |
creator | Gerry, Jon M Pascual, Gabriel |
description | Peroxisome proliferator–activated receptor γ (PPAR γ ) is a nuclear receptor that has been suggested to play protective roles in the pathogenesis of diseases that are characterized by chronic inflammation, such as atherosclerosis. The study of nuclear receptors, including PPAR γ , has led to the discovery of anti-inflammatory processes that are collectively known as transrepression. In this review, we will highlight some of the mechanisms of PPAR γ -mediated transrepression that have surfaced throughout the past decade. We will also discuss the existing evidence for an atheroprotective role of PPARγ as a repressor of inflammatory genes and as a key determinant of distinct monocyte-derived subpopulations that may serve an anti-inflammatory, homeostatic role in atherogenesis. |
doi_str_mv | 10.1016/j.tcm.2007.12.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70345654</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1050173807002575</els_id><sourcerecordid>70345654</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-eb19c1e48e46d85d24bcf5a487b8113a3637f4e983c8025e8822042bf9c443543</originalsourceid><addsrcrecordid>eNp9kUFu1DAUhiMEoqVwADbIK3ZJ34udxAMS0miAglRBVcracpwX6iGJp3Yy0F3v0KP0HhyCk9RhRkJiwcrW0_f_sr-XJM8RMgQsj9fZaPosB6gyzDMAfJAcoqx4mpdYPIx3KCDFisuD5EkIawAoRYmPkwOUHCQu-GEyftLeux92-MbswNzAVto31m11MFOnPXtrA-lAr9jFJbHleEnebbwbyYx2S-zcdcRcy87i-KcNrid25l1nW_J6dP73ze1yBvVIDTsnQ5s4ZL_uniaPWt0FerY_j5Kv799drD6kp59PPq6Wp6kRUI4p1bgwSEKSKBtZNLmoTVtoIataInLNS161ghaSGwl5QVLmOYi8bhdGCF4IfpS83PXGJ19NFEbV22Co6_RAbgqqAi6K8g-IO9B4F4KnVm287bW_VghqVq3WKqpWs2qFuYqqY-bFvnyqe2r-JvZuI_B6B1D84taSV8FYGgw11kd_qnH2v_Vv_kmbzg7W6O47XVNYu8kP0Z1CFWJAfZl3Pa8aKoguqoLfA-ZUpkg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70345654</pqid></control><display><type>article</type><title>Narrowing in on Cardiovascular Disease: The Atheroprotective Role of Peroxisome Proliferator–Activated Receptor γ</title><source>MEDLINE</source><source>ScienceDirect Freedom Collection (Elsevier)</source><creator>Gerry, Jon M ; Pascual, Gabriel</creator><creatorcontrib>Gerry, Jon M ; Pascual, Gabriel</creatorcontrib><description>Peroxisome proliferator–activated receptor γ (PPAR γ ) is a nuclear receptor that has been suggested to play protective roles in the pathogenesis of diseases that are characterized by chronic inflammation, such as atherosclerosis. The study of nuclear receptors, including PPAR γ , has led to the discovery of anti-inflammatory processes that are collectively known as transrepression. In this review, we will highlight some of the mechanisms of PPAR γ -mediated transrepression that have surfaced throughout the past decade. We will also discuss the existing evidence for an atheroprotective role of PPARγ as a repressor of inflammatory genes and as a key determinant of distinct monocyte-derived subpopulations that may serve an anti-inflammatory, homeostatic role in atherogenesis.</description><identifier>ISSN: 1050-1738</identifier><identifier>EISSN: 1873-2615</identifier><identifier>DOI: 10.1016/j.tcm.2007.12.001</identifier><identifier>PMID: 18308193</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Atherosclerosis - physiopathology ; Cardiovascular ; Humans ; Inflammation ; Macrophage Activation ; Macrophages - physiology ; PPAR gamma - physiology ; Receptors, Cytoplasmic and Nuclear - genetics ; Receptors, Cytoplasmic and Nuclear - physiology ; Transcription Factors - physiology</subject><ispartof>Trends in cardiovascular medicine, 2008-02, Vol.18 (2), p.39-44</ispartof><rights>2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-eb19c1e48e46d85d24bcf5a487b8113a3637f4e983c8025e8822042bf9c443543</citedby><cites>FETCH-LOGICAL-c406t-eb19c1e48e46d85d24bcf5a487b8113a3637f4e983c8025e8822042bf9c443543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.tcm.2007.12.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18308193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gerry, Jon M</creatorcontrib><creatorcontrib>Pascual, Gabriel</creatorcontrib><title>Narrowing in on Cardiovascular Disease: The Atheroprotective Role of Peroxisome Proliferator–Activated Receptor γ</title><title>Trends in cardiovascular medicine</title><addtitle>Trends Cardiovasc Med</addtitle><description>Peroxisome proliferator–activated receptor γ (PPAR γ ) is a nuclear receptor that has been suggested to play protective roles in the pathogenesis of diseases that are characterized by chronic inflammation, such as atherosclerosis. The study of nuclear receptors, including PPAR γ , has led to the discovery of anti-inflammatory processes that are collectively known as transrepression. In this review, we will highlight some of the mechanisms of PPAR γ -mediated transrepression that have surfaced throughout the past decade. We will also discuss the existing evidence for an atheroprotective role of PPARγ as a repressor of inflammatory genes and as a key determinant of distinct monocyte-derived subpopulations that may serve an anti-inflammatory, homeostatic role in atherogenesis.</description><subject>Atherosclerosis - physiopathology</subject><subject>Cardiovascular</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Macrophage Activation</subject><subject>Macrophages - physiology</subject><subject>PPAR gamma - physiology</subject><subject>Receptors, Cytoplasmic and Nuclear - genetics</subject><subject>Receptors, Cytoplasmic and Nuclear - physiology</subject><subject>Transcription Factors - physiology</subject><issn>1050-1738</issn><issn>1873-2615</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFu1DAUhiMEoqVwADbIK3ZJ34udxAMS0miAglRBVcracpwX6iGJp3Yy0F3v0KP0HhyCk9RhRkJiwcrW0_f_sr-XJM8RMgQsj9fZaPosB6gyzDMAfJAcoqx4mpdYPIx3KCDFisuD5EkIawAoRYmPkwOUHCQu-GEyftLeux92-MbswNzAVto31m11MFOnPXtrA-lAr9jFJbHleEnebbwbyYx2S-zcdcRcy87i-KcNrid25l1nW_J6dP73ze1yBvVIDTsnQ5s4ZL_uniaPWt0FerY_j5Kv799drD6kp59PPq6Wp6kRUI4p1bgwSEKSKBtZNLmoTVtoIataInLNS161ghaSGwl5QVLmOYi8bhdGCF4IfpS83PXGJ19NFEbV22Co6_RAbgqqAi6K8g-IO9B4F4KnVm287bW_VghqVq3WKqpWs2qFuYqqY-bFvnyqe2r-JvZuI_B6B1D84taSV8FYGgw11kd_qnH2v_Vv_kmbzg7W6O47XVNYu8kP0Z1CFWJAfZl3Pa8aKoguqoLfA-ZUpkg</recordid><startdate>20080201</startdate><enddate>20080201</enddate><creator>Gerry, Jon M</creator><creator>Pascual, Gabriel</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080201</creationdate><title>Narrowing in on Cardiovascular Disease: The Atheroprotective Role of Peroxisome Proliferator–Activated Receptor γ</title><author>Gerry, Jon M ; Pascual, Gabriel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-eb19c1e48e46d85d24bcf5a487b8113a3637f4e983c8025e8822042bf9c443543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Atherosclerosis - physiopathology</topic><topic>Cardiovascular</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Macrophage Activation</topic><topic>Macrophages - physiology</topic><topic>PPAR gamma - physiology</topic><topic>Receptors, Cytoplasmic and Nuclear - genetics</topic><topic>Receptors, Cytoplasmic and Nuclear - physiology</topic><topic>Transcription Factors - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gerry, Jon M</creatorcontrib><creatorcontrib>Pascual, Gabriel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in cardiovascular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gerry, Jon M</au><au>Pascual, Gabriel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Narrowing in on Cardiovascular Disease: The Atheroprotective Role of Peroxisome Proliferator–Activated Receptor γ</atitle><jtitle>Trends in cardiovascular medicine</jtitle><addtitle>Trends Cardiovasc Med</addtitle><date>2008-02-01</date><risdate>2008</risdate><volume>18</volume><issue>2</issue><spage>39</spage><epage>44</epage><pages>39-44</pages><issn>1050-1738</issn><eissn>1873-2615</eissn><abstract>Peroxisome proliferator–activated receptor γ (PPAR γ ) is a nuclear receptor that has been suggested to play protective roles in the pathogenesis of diseases that are characterized by chronic inflammation, such as atherosclerosis. The study of nuclear receptors, including PPAR γ , has led to the discovery of anti-inflammatory processes that are collectively known as transrepression. In this review, we will highlight some of the mechanisms of PPAR γ -mediated transrepression that have surfaced throughout the past decade. We will also discuss the existing evidence for an atheroprotective role of PPARγ as a repressor of inflammatory genes and as a key determinant of distinct monocyte-derived subpopulations that may serve an anti-inflammatory, homeostatic role in atherogenesis.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>18308193</pmid><doi>10.1016/j.tcm.2007.12.001</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1050-1738 |
ispartof | Trends in cardiovascular medicine, 2008-02, Vol.18 (2), p.39-44 |
issn | 1050-1738 1873-2615 |
language | eng |
recordid | cdi_proquest_miscellaneous_70345654 |
source | MEDLINE; ScienceDirect Freedom Collection (Elsevier) |
subjects | Atherosclerosis - physiopathology Cardiovascular Humans Inflammation Macrophage Activation Macrophages - physiology PPAR gamma - physiology Receptors, Cytoplasmic and Nuclear - genetics Receptors, Cytoplasmic and Nuclear - physiology Transcription Factors - physiology |
title | Narrowing in on Cardiovascular Disease: The Atheroprotective Role of Peroxisome Proliferator–Activated Receptor γ |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A15%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Narrowing%20in%20on%20Cardiovascular%20Disease:%20The%20Atheroprotective%20Role%20of%20Peroxisome%20Proliferator%E2%80%93Activated%20Receptor%20%CE%B3&rft.jtitle=Trends%20in%20cardiovascular%20medicine&rft.au=Gerry,%20Jon%20M&rft.date=2008-02-01&rft.volume=18&rft.issue=2&rft.spage=39&rft.epage=44&rft.pages=39-44&rft.issn=1050-1738&rft.eissn=1873-2615&rft_id=info:doi/10.1016/j.tcm.2007.12.001&rft_dat=%3Cproquest_cross%3E70345654%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70345654&rft_id=info:pmid/18308193&rft_els_id=1_s2_0_S1050173807002575&rfr_iscdi=true |